← Leaderboards
Jason Ross Schwartz
Vanderbilt University Medical Center
$760,182
Attributed
$760,182
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $165.3K · FY2020–24$200K$150K$100K$50K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$760,182 · 1
By mechanism
K08$760,182 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Clonal Evolution”
- Priyamvada Acharya · Duke University$16,406,409
- Kamila Naxerova · Massachusetts General Hospital$5,043,192
- Frederic Geissmann · Sloan-Kettering Inst Can Research$5,019,765
- Giannicola Genovese · University Of Tx Md Anderson Can Ctr$3,350,065
- Peter Heshedahl Sudmant · University Of California Berkeley$2,977,610
- Mario Luca Suva · Brigham And Women'S Hospital$2,757,093
Research focus
Clonal EvolutionCytotoxicChromosome 7Clinical PhenotypeAlanine AminopeptidaseCrispr/Cas TechnologyAllelesChildhoodChromosome DeletionChromosomesApoptosisBone Marrow DiseasesArchitectureCohortCaspaseCd34 GeneCell CountCell Cycle ArrestCell LineAutophagocytosisCellsAnxa5 GeneCellular AssayDifferential Expression
Grant awards (6)
Hematopoietic consequences of gain-of-function SAMD9 and SAMD9L mutations$148,716
K08 · FY2024 · HL · contact PI
Hematopoietic consequences of gain-of-function SAMD9 and SAMD9L mutations$148,716
K08 · FY2023 · HL · contact PI
Hematopoietic consequences of gain-of-function SAMD9 and SAMD9L mutations$148,716
K08 · FY2022 · HL · contact PI
Hematopoietic consequences of gain-of-function SAMD9 and SAMD9L mutations$148,716
K08 · FY2021 · HL · contact PI
Hematopoietic consequences of gain-of-function SAMD9 and SAMD9L mutations$108,476
K08 · FY2020 · HL · contact PI
Hematopoietic consequences of gain-of-function SAMD9 and SAMD9L mutations$56,842
K08 · FY2020 · HL · contact PI